A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.

HomeNews & ResourcesSpotlightSpotlight on… Alexander Santos, Vice President, Clinical...
image

Alexander Santos is the Vice President of Clinical Trial Supply in the US and has been a Board Member of Bionical Emas Inc. since 2017. Alex has 30 years of experience within the Clinical Trial Supply sector and has been involved in packaging and labeling as well as managing Clinical Trial Supply for various pharmaceutical companies. He has a passion to deliver the ultimate customer service experience.

As Vice President of Clinical Trial Supply (CTS), Alex is responsible for growing the business by focusing on customer acquisition and retention, through identifying strategic opportunities within the new and current customer base.

Even though the primary focus of CTS is the sourcing of commercial medicines (including; comparator, co-meds, ancillaries) for use in clinical development programs, Alex and his Team go beyond that by assisting clients with product forecasting, packaging and labeling and site distribution services.

In recent months, Alex has taken on the responsibility of setting up our US Warehouse and Distribution Center in New Jersey which will be open in Summer 2021. This task required development of floor plans and contracting with various vendors to ensure that all duties are carried out in compliance with the businesses applicable quality processes and SOPs, Good Manufacturing Practice (GMP), Good Distribution Practice (GDP) and within all applicable licensing/regulatory requirements.

This facility will also include labeling suites to assist our customers to facilitate a tailored labeling solution to meet their clinical study need, either through an On-Demand or Traditional Labeling solution. We feel with this service we can help our clients get to First Patient In (FPI) in a much more efficient and timely manner.

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.